SCOTT Z FIELDS
Medical Practice in Towaco, NJ
License number
Pennsylvania MD058431L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Towaco, NJ 07082
Pennsylvania
Pennsylvania
Personal information
See more information about SCOTT Z FIELDS at radaris.comName
Address
Phone
5156 Wynnewood Rd, Harrisburg, PA 17109
4 Fabio Ct, Neptune, NJ 07753
4992 Thornbury Cir, Douglassville, PA 19518
5715 Vandike St, Philadelphia, PA 19135
4615 Crosswinds Dr, Erie, PA 16506
Professional information
Dihydropyridine Compounds For Neurodegenerative Diseases And Dementia
US Patent:
2009013, May 21, 2009
Filed:
Apr 4, 2006
Appl. No.:
11/887729
Inventors:
Julian A. Gray - Inzlingen, DE
Yoshiharu Yamanishi - Ibaraki, JP
Nobuyuki Mori - Ibaraki, JP
Scott Fields - Towaco NJ, US
Yoshiharu Yamanishi - Ibaraki, JP
Nobuyuki Mori - Ibaraki, JP
Scott Fields - Towaco NJ, US
Assignee:
EISAI Co., Ltd. - Tokyo
International Classification:
A61K 31/444, A61P 25/28
US Classification:
514332
Abstract:
The invention provides methods for treating and/or preventing cognitive impairments, dementia, or neurodegenerative diseases and disorders (e.g., Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis) in patients by administering therapeutically effective amounts of an AMPA receptor antagonist (e.g., 1,2-dihydropyridine compounds) and therapeutically effective amounts of nootropics (e.g., cholinesterase inhibitors) to patients. The invention also provides combinations, commercial packages, and pharmaceutical compositions comprising therapeutically effective amounts of AMPA receptor antagonists (e.g., 1,2-dihydropyridine compounds) and therapeutically effective amounts nootropics (e.g., cholinesterase inhibitors). The 1,2-dihydropyridine compound may be, for example, 3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one. The cholinesterase inhibitor may be, for example, donepezil.
Dihydropyridine Compounds And Compositions For Headaches
US Patent:
2006027, Nov 30, 2006
Filed:
Apr 4, 2006
Appl. No.:
11/396555
Inventors:
Julian Gray - Inzlingen, DE
Yoshiharu Yamanishi - Tsukuba-shi, JP
Nobuyuki Mori - Tsukuba-shi, JP
Scott Fields - Towaco NJ, US
Yoshiharu Yamanishi - Tsukuba-shi, JP
Nobuyuki Mori - Tsukuba-shi, JP
Scott Fields - Towaco NJ, US
Assignee:
Eisai Co. Ltd. - Bunkyo-ku
International Classification:
A61K 31/445, A61K 31/444
US Classification:
514332000, 514319000
Abstract:
The invention provides methods for treating and/or preventing cognitive impairments, dementia, or neurodegenerative diseases and disorders (e.g., Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis) in patients by administering therapeutically effective amounts of an AMPA receptor antagonist (e.g., 1,2-dihydropyridine compounds) and therapeutically effective amounts of nootropics (e.g., cholinesterase inhibitors) to patients. The invention also provides combinations, commercial packages, and pharmaceutical compositions comprising therapeutically effective amounts of AMPA receptor antagonists (e.g., 1,2-dihydropyridine compounds) and therapeutically effective amounts nootropics (e.g., cholinesterase inhibitors). The 1,2-dihydropyridine compound may be, for example, 3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one. The cholinesterase inhibitor may be, for example, donepezil.
Compositions And Methods For Cancer Immunotherapy
US Patent:
2014006, Mar 6, 2014
Filed:
Nov 8, 2013
Appl. No.:
14/075130
Inventors:
- Tokyo, JP
Sally T. Ishizaka - Weston MA, US
Lynn D. Hawkins - Andover MA, US
Scott Fields - Towaco NJ, US
Sally T. Ishizaka - Weston MA, US
Lynn D. Hawkins - Andover MA, US
Scott Fields - Towaco NJ, US
Assignee:
Eisai R&D Management Co., Ltd. - Tokyo
International Classification:
A61K 39/00, A61K 45/06
US Classification:
424 852, 4242771, 4242041, 4242271, 4242281, 4242301, 4242291, 4241331, 4241311, 424 851
Abstract:
The invention relates to immunotherapeutic compounds and to methods for stimulating an immune response in a subject individual at risk for developing cancer, diagnosed with a cancer, in treatment for cancer, or in post-therapy recovery from cancer or the compounds of the invention can be administered as a prophylactic to a subject individual to prevent or delay the development of cancer.
Compositions And Methods For Cancer Immunotherapy
US Patent:
7976852, Jul 12, 2011
Filed:
Apr 26, 2006
Appl. No.:
11/411332
Inventors:
Daniel P. Rossignol - Ridgefield Park NJ, US
Sally T. Ishizaka - Weston MA, US
Lynn D. Hawkins - Concord MA, US
Scott Z. Fields - Towaco NJ, US
Sally T. Ishizaka - Weston MA, US
Lynn D. Hawkins - Concord MA, US
Scott Z. Fields - Towaco NJ, US
Assignee:
Eisai R&D Management Co., Ltd. - Tokyo
International Classification:
A61K 31/395
US Classification:
4242771, 4241781, 5142633, 514183, 514269
Abstract:
The invention relates to immunotherapeutic compounds and to methods for stimulating an immune response in a subject individual at risk for developing cancer, diagnosed with a cancer, in treatment for cancer, or in post-therapy recovery from cancer or the compounds of the invention can be administered as a prophylactic to a subject individual to prevent or delay the development of cancer.
Compositions And Methods For Cancer Immunotherapy
US Patent:
8603482, Dec 10, 2013
Filed:
Jun 13, 2011
Appl. No.:
13/158786
Inventors:
Daniel P. Rossignol - Ridgefield Park NJ, US
Sally T. Ishizaka - Weston MA, US
Lynn D. Hawkins - Andover MA, US
Scott Fields - Towaco NJ, US
Sally T. Ishizaka - Weston MA, US
Lynn D. Hawkins - Andover MA, US
Scott Fields - Towaco NJ, US
Assignee:
Eisai R&D Management Co., Ltd. - Bunkyo-Ku, Tokyo
International Classification:
A61K 39/395, A61P 35/00
US Classification:
4241741, 4242781
Abstract:
The invention relates to immunotherapeutic compounds and to methods for stimulating an immune response in a subject individual at risk for developing cancer, diagnosed with a cancer, in treatment for cancer, or in post-therapy recovery from cancer or the compounds of the invention can be administered as a prophylactic to a subject individual to prevent or delay the development of cancer.
Compositions And Methods For Immunotherapy
US Patent:
2011024, Oct 6, 2011
Filed:
Apr 8, 2011
Appl. No.:
13/082720
Inventors:
Scott Z. Fields - Towaco NJ, US
Lynn D. HAWKINS - Andover MA, US
Sally T. ISHIZAKA - Weston MA, US
Daniel P. ROSSIGNOL - Ridgefield Park NJ, US
Lynn D. HAWKINS - Andover MA, US
Sally T. ISHIZAKA - Weston MA, US
Daniel P. ROSSIGNOL - Ridgefield Park NJ, US
Assignee:
Eisai R&D Management Co., Ltd. - Tokyo
International Classification:
A61K 39/395, A61P 35/00
US Classification:
4241331, 4241301, 4241741, 4241421
Abstract:
The invention relates to immunotherapeutic compounds, compositions that include such compounds, and methods of using the compounds, for example, to treat an individual having, at risk for, or previously treated for a cancer.
Novel Deazapurines And Uses Thereof
US Patent:
2004018, Sep 23, 2004
Filed:
Jan 7, 2004
Appl. No.:
10/753261
Inventors:
Jane Daun - Dracut MA, US
Scott Fields - Towaco NJ, US
Seiichi Kobayashi - Belmont MA, US
Scott Fields - Towaco NJ, US
Seiichi Kobayashi - Belmont MA, US
Assignee:
Eisai Co., Ltd. - Tokyo
International Classification:
C07D471/02, A61K031/4745
US Classification:
514/303000, 546/119000
Abstract:
The present invention provides methods of using compounds having formula (I):
wherein R, R, Rand n are as described generally and in classes and subclasses herein, in the treatment of reperfusion injuries, osteoporosis and/or bone metastasis.